Related Experiment Videos

Anticancer effects of fenretinide in human medulloblastoma

C Damodar Reddy1, Asha Guttapalli, Peter C Adamson

  • 1Division of Neuro-Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. reddyd@email.chop.edu

Cancer Letters
|January 10, 2006
PubMed

Insights

Fenretinide, a synthetic retinoid, effectively induces cell death in medulloblastoma (MB) cells. This study highlights its potential as a therapeutic agent for treating this childhood brain tumor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • N-(4-hydroxyphenyl) retinamide (4-HPR, fenretinide) is a synthetic retinoid investigated for various cancers.
  • The therapeutic potential of fenretinide in medulloblastoma (MB), a common childhood brain tumor, remains unexplored.

Purpose of the Study:

  • To investigate the biological effects and therapeutic potential of fenretinide in human medulloblastoma cells.
  • To determine if fenretinide can induce cell death and inhibit survival in MB cell lines.

Main Methods:

  • Utilized MTT assays to assess cell viability and survival.
  • Evaluated anchorage-independent colony formation in soft agar.
  • Assessed caspase-3 activation and poly(ADP-ribose) polymerase-1 (PARP-1) cleavage.

Main Results:

  • Fenretinide (2.5-10 microM) significantly inhibited cell survival in four human MB cell lines.
  • Observed inhibition of anchorage-independent colony formation.
  • Demonstrated fenretinide-induced apoptosis via caspase-3 activation and PARP-1 cleavage.
  • Identified a partial protective effect of l-ascorbic acid, suggesting a role for free radicals.

Conclusions:

  • Pharmacologically achievable concentrations of fenretinide are effective in inducing cell death in human medulloblastoma cells.
  • Fenretinide exhibits therapeutic potential for treating human medulloblastoma.
  • The mechanism involves caspase-3 dependent apoptosis, potentially mediated by free radical intermediates.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...